ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,168.20
-1.70%
S&P ASX All Technology
3,794.30
-2.54%
Brent Oil
72.70
-0.05%
US Dollar vs AUD
1.60798
-0.23%
Bitcoin
101,188.66
1.12%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Gelteq Ltd (GELS) Share Price

Gelteq Ltd

Gelteq Ltd (GELS)

NASDAQ
2.23
-1.06
(-32.22%)
Closed 19 December 8:00AM
Delayed by 15 minutes
2.37
0.14
(6.28%)
After Hours: 11:59AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
2.37
Bid
2.42
Offer
2.50
Volume
344,715
2.23 Day's Range 3.30
1.42 52 Week Range 5.50
Previous Close
3.29
Open
3.05
Last Trade
4
@
2.42
Last Trade Time
Average Volume (3m)
583,931
Financial Volume
US$ 1,007,933
VWAP
2.924

Ask ADVFN Intelligence (AI)

GELS Latest News

More News

Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug

NEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and biotechnology company focused on developing and commercializing white label...

18 December 2024
GlobeNewswire Inc.

Gelteq to Participate in the Benchmark Company 13th Annual Discovery Investor Conference

NEW YORK, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing...

10 December 2024
GlobeNewswire Inc.

Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand

NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing...

03 December 2024
GlobeNewswire Inc.

Gelteq Announces 400,000 Units Enter into Production in November 2024

NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company focused on developing and commercializing white label...

27 November 2024
GlobeNewswire Inc.

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

16 November 2024
Edgar (US Regulatory)

Gelteq Expands Operations in United States with Appointment of Adam Bendell as President of U.S. Operations to Scale Domestic Business

NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing...

13 November 2024
GlobeNewswire Inc.

Form NT 20-F - Notification of inability to timely file Form 20-F

01 November 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

31 October 2024
Edgar (US Regulatory)

Gelteq Limited Closes US$5.2 Million Initial Public Offering

NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of...

31 October 2024
GlobeNewswire Inc.

Gelteq Limited Prices US$5.2 Million Initial Public Offering

NEW YORK, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of...

29 October 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-2.13-47.33333333334.55.142.234028103.79432035CS
40.7546.29629629631.625.51.4210021573.82971606CS
12-1.63-40.7545.51.425839313.76092875CS
26-1.63-40.7545.51.425839313.76092875CS
52-1.63-40.7545.51.425839313.76092875CS
156-1.63-40.7545.51.425839313.76092875CS
260-1.63-40.7545.51.425839313.76092875CS

GELS - Frequently Asked Questions (FAQ)

What is the current Gelteq share price?
The current share price of Gelteq is US$ 2.37
What is the 1 year trading range for Gelteq share price?
Gelteq has traded in the range of US$ 1.42 to US$ 5.50 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LITMSnow Lake Resources Ltd
US$ 0.7943
(334.04%)
1.19B
NUKKNukkleus Inc
US$ 50.68
(326.60%)
53.58M
PLRZPolyrizon Ltd
US$ 3.256
(210.10%)
136.74M
QMCOQuantum Corporation
US$ 60.085
(153.31%)
22.59M
VRARGlimpse Group Inc
US$ 3.1885
(100.53%)
54.75M
XCHXCHG Ltd
US$ 2.16
(-90.74%)
11.17M
FTELFitell Corporation
US$ 5.50
(-85.67%)
1.68M
XHGXChange TED Inc
US$ 0.754
(-52.28%)
549.34k
MHUAMeihua International Medical Technologies Company Ltd
US$ 0.2755
(-43.82%)
8.86M
RNAZTransCode Therapeutics Inc
US$ 3.915
(-38.00%)
854.5k
LITMSnow Lake Resources Ltd
US$ 0.7943
(334.04%)
1.2B
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.3671
(9.94%)
317.96M
CGTXCognition Therapeutics Inc
US$ 0.58295
(28.15%)
287.37M
RGTIRigetti Computing Inc
US$ 10.684
(-4.01%)
280.37M
NVDANVIDIA Corporation
US$ 128.91
(-1.14%)
277.36M

Discussion

View Full Feed
colorfullife88200 colorfullife88200 2 minutes ago
After the investor day, big boys should load up, tomorrow $3.50 ?
ILLR
$0.45 $0.45 3 minutes ago
Just believe and you see 👀 the money 💰 🤑 💸
HMBL
OTCWealth101 OTCWealth101 4 minutes ago
They need to cancel 10 billion shares for the fat pig to move
Genz2 Genz2 5 minutes ago
https://www.businesswire.com/news/home/20240910298690/en/Intertrust-Showcases-Trusted-Media-Green-Streaming-Solution-and-Web3-Experiences-at-IBC-2024

Methinks, do you remember when Wave had a deal with Intertrust? I do!! It was back in the days of Peter Sprague!! Maybe Wave will sa
RickNagra RickNagra 5 minutes ago
Start at approximately 37:20 time mark.

https://knowledge.wharton.upenn.edu/article/is-the-american-dream-of-homeownership-still-within-reach/
FNMA
shajandr shajandr 7 minutes ago
LOLOL!! Horseshit. CMW offers nuthin.

Absurd. And absurd that anyone still bleeves this utter nonsense.

https://investorshub.advfn.com/uimage/uploads/2024/12/16/eozuomrgetruth2.jpg
MRGE
jxyzobrien jxyzobrien 9 minutes ago
flash crash and japan
shane smoleny called flash crash perfectly
He said his astro indicators were setup for the perfect storm

Japan did not raise rates and yen fell
World markets ignored the fed
so this was just USA related

futures not movi
Matt24777 Matt24777 10 minutes ago
BULLISH 
SVTE
Think1st Think1st 13 minutes ago
Notice to board

no change to our account, still worthless
INQD
HappyAlways HappyAlways 14 minutes ago
You are wrong many times already.

The excessive NWS payments carries 10% annual interest (as per the same interest rate charged to the PSPA loan). If there is no NWS, the payments in excess of 10% original interest in 2012 alone should accumulate to almost $300B. That's fact. Check y
FNMA
Bright Boy Bright Boy 14 minutes ago
Nice post for the Holidays:

https://x.com/RichFairgrieve/status/1869577235226853556

Cheers,

BB
NWBO
Shawonsarker84 Shawonsarker84 15 minutes ago
I am giving it sixty days 🤣. Let the market decide.
HMBL
Oleblue Oleblue 16 minutes ago
2024 Chicago Quantum Summit — Charina Chou

https://youtu.be/4UiLCsl1om8

https://api.wsj.net/api/kaavio/charts/big.chart?nosettings=1&symb=goog&uf=32&type=4&size=4&sid=14766457&style=330&freq=2&entitlementtoken=0c33378313484ba9b46b8e24ded87dd6&time=11&rand=89404171&compi
GOOG
robinandthe7hoods robinandthe7hoods 16 minutes ago
https://deniseholt.us/verses-ai-crushes-openai-o1-in-head-to-head-competition/
VRSSF
robinandthe7hoods robinandthe7hoods 18 minutes ago
After the latest PR,Tobin Smith was telling his followers that Verses was going to 50x.
Yesterday,after Denise Holt's latest writeup,which was quite impressive,Tobin Smith has changed his target to 100x.
He should have a new newsletter for his followers going into the weeken
VRSSF
georgejjl georgejjl 21 minutes ago
This is an on topic post. Expect VERY VERY OOD NEWS regarding AVXL TOMORROW!!!

Good luck and GOD bless,
AVXL
theswordman theswordman 23 minutes ago
Thanks for the medical advice. Your expertise in multi areas is impressive
BIXT
Bigfootbud Bigfootbud 23 minutes ago
Love you!!! And al!! 2 Corinthians 4:18 So we fix our eyes not on what is seen, but on what is unseen, since what is seen is temporary, but what is unseen is eternal.
Adam917 Adam917 25 minutes ago
I can see fb and they don't even maintain fb. See this lol
https://investorshub.advfn.com/uimage/uploads/2024/12/19/fqzybScreenshot_2024-12-19_at_11.07.30%E2%80%AFAM.png
UATG
Bigfootbud Bigfootbud 26 minutes ago
why did I originally block you?? ♥
HIRU
skitahoe skitahoe 28 minutes ago
I realize that what you're saying is probably the case, but has LP actually ever said so. I know that Merck had an exec working at the company and clearly they have the inside track, but I don't know that we won't be surprised by all the the trials that may be starting in the not too distant future
NWBO
boi568 boi568 29 minutes ago
An abrupt rate increase of 62 percent is beyond existing inflation or insurance trends. It is certainly locational -- fire, flood, earthquake (I will guess flood) -- and, as you point out, has to be justified to state insurance regulators. It's also possible that federal guarantees have been pulled.
AVXL
Bigfootbud Bigfootbud 31 minutes ago
expansion is not a negative. ♥
RDGL
trip01fun trip01fun 35 minutes ago
thank you
ECMH

Your Recent History

NASDAQ
GELS
Gelteq
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved